From the MDS Beacon...
Exjade May Improve Blood Cell Counts And Reduce Transfusion Needs In MDS Patients
by Jessica Langholtz
Results from a European study demonstrate that Exjade, a treatment for excess iron, may improve blood cell counts and reduce the need for red blood cell transfusions in myelodysplastic syndromes patients.
However, the study investigators point out that further prospective, randomized trials are necessary to confirm these findings.
For the rest, see the article at MDS Beacon.